Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases

Brain metastases cause significant morbidity and mortality in patients with advanced cancer. In the era of precision oncology and immunotherapy, there are rapidly evolving systemic treatment options. These novel therapies may have variable intracranial efficacy, and patients with brain metastases re...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Aaron C., Boggs, Drexell H., Lee, Eudocia Q., Kim, Michelle M., Mehta, Minesh P., Khasraw, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761732/
https://www.ncbi.nlm.nih.gov/pubmed/35047397
http://dx.doi.org/10.3389/fonc.2021.780379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761732/
https://www.ncbi.nlm.nih.gov/pubmed/35047397
http://dx.doi.org/10.3389/fonc.2021.780379

Ejemplares similares